<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: menopause</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Researchers slow immune attack on ovaries in mice</title>
   	 <description>(Medical Xpress) -- In a study of mice, researchers have slowed an immune system attack on the ovaries. The mice developed a disorder resembling primary ovarian insufficiency (POI), a menopause-like condition that affects women under the age of 40, sometimes years or even decades before normal menopause. The study was conducted by scientists at the National Institutes of Health and the University of California, San Francisco (UCSF).</description>
	  <link>http://medicalxpress.com/news/2011-06-immune-ovaries-mice.html</link>
	 <category>Medical research</category>
	 <pubDate>Tue, 21 Jun 2011 10:04:33 EST</pubDate>
	 <guid isPermaLink="false">news227869444</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2011/nihresearche.jpg" width="90" height="90" />
</item>
<item>
     <title>Women with BRCA mutations can take hormone-replacement therapy safely after ovary removal</title>
   	 <description>Women with the BRCA1 or BRCA2 gene mutations, which are linked to a very high risk of breast and ovarian cancer, can safely take hormone-replacement therapy (HRT) to mitigate menopausal symptoms after surgical removal of their ovaries, according to new research from the Perelman School of Medicine at the University of Pennsylvania which will be presented Monday, June 6 during the American Society for Clinical Oncology's annual meeting (Abstract #1501). Results of the prospective study indicated that women with BRCA mutations who had their ovaries removed and took short-term HRT had a decrease in the risk of developing breast cancer.</description>
	  <link>http://medicalxpress.com/news/2011-06-women-brca-mutations-hormone-replacement-therapy.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 01 Jun 2011 15:03:00 EST</pubDate>
	 <guid isPermaLink="false">news226159355</guid>
	 
</item>
<item>
     <title>Study: Hormone level predicts end of fertility</title>
   	 <description>The age-specific blood levels of the Anti-Mullerian hormone (AMH) can predict when women will reach menopause. This makes family planning easier, say fertility researchers from the University Medical Center Utrecht, The Netherlands. Their findings were published online May 26 in the Journal of Clinical Endocrinology &amp; Metabolism.</description>
	  <link>http://medicalxpress.com/news/2011-05-hormone-fertility.html</link>
	 <category>Medical research</category>
	 <pubDate>Thu, 26 May 2011 10:13:00 EST</pubDate>
	 <guid isPermaLink="false">news225623546</guid>
	 
</item>
<item>
     <title>Coffee reduces breast cancer risk: new study</title>
   	 <description>Recently published research shows that coffee drinkers enjoy not only the taste of their coffee but also a reduced risk of cancer with their cuppa. More detailed research published today in BioMed Central's open access journal Breast Cancer Research shows that drinking coffee specifically reduces the risk of antiestrogen-resistant estrogen-receptor (ER)-negative breast cancer.</description>
	  <link>http://medicalxpress.com/news/2011-05-coffee-breast-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 11 May 2011 03:32:02 EST</pubDate>
	 <guid isPermaLink="false">news224303484</guid>
	 
</item>
<item>
     <title>The contraceptive pill and HRT may protect against cerebral aneurysm</title>
   	 <description>Women who develop cerebral aneurysms are less likely to have taken the oral contraceptive pill or hormone replacement therapy, suggesting taking oestrogen could have a protective effect, reveals research published in the Journal of NeuroInterventional Surgery.</description>
	  <link>http://medicalxpress.com/news/2011-05-contraceptive-pill-hrt-cerebral-aneurysm.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Thu, 05 May 2011 04:31:29 EST</pubDate>
	 <guid isPermaLink="false">news223788443</guid>
	 
</item>
<item>
     <title>Male menopause: The lowdown on 'low T'</title>
   	 <description>Is there such a thing as male menopause? In women, menopause is characterized by a cessation of fertility and a sharp drop in certain hormone levels at midlife. In that sense, men don't go through their own version of menopause. Instead, men generally experience a slow but steady decline in testosterone over the decades, mostly after age 50. If a man's testosterone level drops substantially (and especially if this causes adverse effects), it's often called andropause or late-onset hypogonadism -- though there&amp;#146;s much controversy about how to define this and thus how common it is.</description>
	  <link>http://medicalxpress.com/news/2011-04-male-menopause-lowdown.html</link>
	 <category>Other</category>
	 <pubDate>Tue, 12 Apr 2011 14:20:50 EST</pubDate>
	 <guid isPermaLink="false">news221836835</guid>
	 
</item>
<item>
     <title>Estrogen treatment with no side-effects in sight</title>
   	 <description>Oestrogen treatment for osteoporosis has often been associated with serious side-effects. Researchers at the Sahlgrenska Academy, University of Gothenburg, Sweden, have now, in mice, found a way of utilising the positive effects of oestrogen in mice so that only the skeleton is acted on, current research at the Academy shows.</description>
	  <link>http://medicalxpress.com/news/2011-04-estrogen-treatment-side-effects-sight.html</link>
	 <category>Medical research</category>
	 <pubDate>Mon, 11 Apr 2011 16:12:32 EST</pubDate>
	 <guid isPermaLink="false">news221757139</guid>
	 
</item>


</channel>
</rss>
